IDXX
Price
$531.32
Change
+$3.54 (+0.67%)
Updated
Jun 27 closing price
Capitalization
44.84B
36 days until earnings call
WAT
Price
$352.41
Change
-$2.50 (-0.70%)
Updated
Jun 27 closing price
Capitalization
20.38B
37 days until earnings call
Interact to see
Advertisement

IDXX vs WAT

Header iconIDXX vs WAT Comparison
Open Charts IDXX vs WATBanner chart's image
IDEXX Laboratories
Price$531.32
Change+$3.54 (+0.67%)
Volume$624.77K
Capitalization44.84B
Waters
Price$352.41
Change-$2.50 (-0.70%)
Volume$807.5K
Capitalization20.38B
IDXX vs WAT Comparison Chart in %
Loading...
IDXX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
WAT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IDXX vs. WAT commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IDXX is a Buy and WAT is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (IDXX: $531.32 vs. WAT: $352.41)
Brand notoriety: IDXX and WAT are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: IDXX: 96% vs. WAT: 159%
Market capitalization -- IDXX: $44.84B vs. WAT: $20.38B
IDXX [@Medical Specialties] is valued at $44.84B. WAT’s [@Medical Specialties] market capitalization is $20.38B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.65B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IDXX’s FA Score shows that 2 FA rating(s) are green whileWAT’s FA Score has 1 green FA rating(s).

  • IDXX’s FA Score: 2 green, 3 red.
  • WAT’s FA Score: 1 green, 4 red.
According to our system of comparison, WAT is a better buy in the long-term than IDXX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IDXX’s TA Score shows that 3 TA indicator(s) are bullish while WAT’s TA Score has 4 bullish TA indicator(s).

  • IDXX’s TA Score: 3 bullish, 3 bearish.
  • WAT’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, WAT is a better buy in the short-term than IDXX.

Price Growth

IDXX (@Medical Specialties) experienced а +1.41% price change this week, while WAT (@Medical Specialties) price change was +2.85% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +1.14%. For the same industry, the average monthly price growth was +1.17%, and the average quarterly price growth was -0.01%.

Reported Earning Dates

IDXX is expected to report earnings on Aug 04, 2025.

WAT is expected to report earnings on Aug 05, 2025.

Industries' Descriptions

@Medical Specialties (+1.14% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IDXX($44.8B) has a higher market cap than WAT($20.4B). IDXX has higher P/E ratio than WAT: IDXX (52.87) vs WAT (31.78). IDXX YTD gains are higher at: 28.512 vs. WAT (-5.006). IDXX has higher annual earnings (EBITDA): 1.22B vs. WAT (1B). IDXX has more cash in the bank: 454M vs. WAT (396M). IDXX has less debt than WAT: IDXX (1.07B) vs WAT (2.44B). IDXX has higher revenues than WAT: IDXX (3.66B) vs WAT (2.96B).
IDXXWATIDXX / WAT
Capitalization44.8B20.4B220%
EBITDA1.22B1B122%
Gain YTD28.512-5.006-570%
P/E Ratio52.8731.78166%
Revenue3.66B2.96B124%
Total Cash454M396M115%
Total Debt1.07B2.44B44%
FUNDAMENTALS RATINGS
IDXX vs WAT: Fundamental Ratings
IDXX
WAT
OUTLOOK RATING
1..100
6621
VALUATION
overvalued / fair valued / undervalued
1..100
87
Overvalued
80
Overvalued
PROFIT vs RISK RATING
1..100
5848
SMR RATING
1..100
1723
PRICE GROWTH RATING
1..100
1555
P/E GROWTH RATING
1..100
5238
SEASONALITY SCORE
1..100
8595

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

WAT's Valuation (80) in the Medical Specialties industry is in the same range as IDXX (87). This means that WAT’s stock grew similarly to IDXX’s over the last 12 months.

WAT's Profit vs Risk Rating (48) in the Medical Specialties industry is in the same range as IDXX (58). This means that WAT’s stock grew similarly to IDXX’s over the last 12 months.

IDXX's SMR Rating (17) in the Medical Specialties industry is in the same range as WAT (23). This means that IDXX’s stock grew similarly to WAT’s over the last 12 months.

IDXX's Price Growth Rating (15) in the Medical Specialties industry is somewhat better than the same rating for WAT (55). This means that IDXX’s stock grew somewhat faster than WAT’s over the last 12 months.

WAT's P/E Growth Rating (38) in the Medical Specialties industry is in the same range as IDXX (52). This means that WAT’s stock grew similarly to IDXX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IDXXWAT
RSI
ODDS (%)
Bearish Trend 3 days ago
80%
N/A
Stochastic
ODDS (%)
Bearish Trend 3 days ago
64%
Bearish Trend 3 days ago
65%
Momentum
ODDS (%)
Bullish Trend 3 days ago
74%
Bullish Trend 3 days ago
62%
MACD
ODDS (%)
N/A
Bullish Trend 3 days ago
74%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
66%
Bullish Trend 3 days ago
67%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
61%
Bearish Trend 3 days ago
63%
Advances
ODDS (%)
N/A
Bullish Trend 4 days ago
67%
Declines
ODDS (%)
Bearish Trend 4 days ago
70%
Bearish Trend 12 days ago
60%
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bullish Trend 3 days ago
61%
Bearish Trend 3 days ago
48%
View a ticker or compare two or three
Interact to see
Advertisement
IDXX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
WAT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
ETO27.080.30
+1.12%
Eaton Vance Tax-Advantaged Global Div Oppor Fund
DON49.970.05
+0.10%
WisdomTree US MidCap Dividend ETF
NAZ11.57N/A
-0.04%
Nuveen Arizona Quality Municipal Income Fund
JHHY25.72-0.02
-0.09%
JHancock High Yield ETF
PXJ24.00-0.19
-0.77%
Invesco Oil & Gas Services ETF

IDXX and

Correlation & Price change

A.I.dvisor indicates that over the last year, IDXX has been loosely correlated with RVTY. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if IDXX jumps, then RVTY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IDXX
1D Price
Change %
IDXX100%
+0.67%
RVTY - IDXX
52%
Loosely correlated
-0.98%
A - IDXX
52%
Loosely correlated
-0.21%
MTD - IDXX
51%
Loosely correlated
-0.73%
SYK - IDXX
49%
Loosely correlated
+0.81%
WAT - IDXX
47%
Loosely correlated
-0.70%
More

WAT and

Correlation & Price change

A.I.dvisor indicates that over the last year, WAT has been closely correlated with A. These tickers have moved in lockstep 81% of the time. This A.I.-generated data suggests there is a high statistical probability that if WAT jumps, then A could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To WAT
1D Price
Change %
WAT100%
-0.70%
A - WAT
81%
Closely correlated
-0.21%
MTD - WAT
76%
Closely correlated
-0.73%
RVTY - WAT
71%
Closely correlated
-0.98%
TMO - WAT
70%
Closely correlated
-0.93%
BRKR - WAT
69%
Closely correlated
-0.90%
More